Publicaciones en colaboración con investigadoras/es de Hospital Clinic Barcelona (16)

2023

  1. Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosis

    Journal of Hepatology, Vol. 78, Núm. 4, pp. 794-804

2022

  1. Effects of everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 6, pp. 335-342

2021

  1. Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects

    Liver International, Vol. 41, Núm. 9, pp. 2076-2086

  2. Liver transplant with controlled donors after circulatory death with normothermic regional perfusion and brain dead donors: A multicenter cohort study of transfusion, one-year graft survival and mortality

    International Journal of Surgery, Vol. 96

2020

  1. Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis

    Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 1, pp. 216-225.e5

  2. Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH

    Journal of Hepatology, Vol. 73, Núm. 1, pp. 17-25

2019

  1. A survey of Heads of Surgery and Residents on accessibility and employment in liver transplant teams in Spain

    Cirugia Espanola, Vol. 97, Núm. 10, pp. 560-567

2014

  1. IV Reunión de Consenso de la Sociedad Española de Trasplante Hepático 2012. Excepciones al Model for End-stage Liver Disease en la priorización para trasplante hepático

    Gastroenterologia y Hepatologia, Vol. 37, Núm. 2, pp. 83-91

  2. Use of artificial intelligence as an innovative donor-recipient matching model for liver transplantation: Results from a multicenter Spanish study

    Journal of Hepatology, Vol. 61, Núm. 5, pp. 1020-1028

2013

  1. Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease

    Hepatology, Vol. 57, Núm. 2, pp. 505-514

2012

  1. Hepatoma cells from mice deficient in glycine N-methyltransferase have increased RAS signaling and activation of liver kinase B1

    Gastroenterology, Vol. 143, Núm. 3

2011

  1. A prospective, multicenter study of once-daily extended-release tacrolimus in de novo liver transplant recipients

    Transplantation Proceedings

2010

  1. Tratamiento del carcinoma hepatocelular en España. Análisis de 705 casos en 62 centros

    Medicina Clinica, Vol. 134, Núm. 13, pp. 569-576

1999

  1. Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials

    Hepatology, Vol. 29, Núm. 1, pp. 62-67

1998

  1. Simultaneous presentation of autoimmune thyroiditis and celiac disease in an adult

    Gastroenterología y hepatología, Vol. 21, Núm. 9, pp. 442-444

1997

  1. Pulmonary abscess as a complication of transarterial embolization of multinodular hepatocellular carcinoma

    American Journal of Gastroenterology, Vol. 92, Núm. 10, pp. 1942-1943